Financial results for Q2 2021 just released: Group revenue up 1.3%
In Q2, we saw continued strong growth within the Life Sciences International business, and we strengthened this business further with the addition of SL Controls. Once again, our Winning Solutions strategy gained traction, as it now constitutes 52% of NNIT’s revenue compared to 44% in the same period last year.
NNIT further strengthens its Production IT solutions with the acquisition of Irish-based SL Controls
NNIT and SL Controls have agreed to join forces. SL Controls will further strengthen NNIT’s solutions within Production IT and is yet another step towards consolidating the NNIT Group as one of the foremost suppliers of IT services to the global life sciences industry.
New CEO to drive NNIT’s continued strategic journey
Today, NNIT’s Board of Directors have entered into an agreement with Pär Fors who will join NNIT as CEO as of June 14, 2021. Pär Fors will replace Per Kogut who has served as NNIT’s CEO since 2007.
Financial results for Q1 2021 just released: Group revenue up 1.2%
In Q1, we experienced continued strong growth within the International Life Sciences business, with Excellis performing to plan. Our Private & Public business started to see positive momentum in relation to the Winning Solutions strategy, which now constitutes 49% of NNIT’s revenue.
Lonza and NNIT partner to speed up MES projects
Across the life sciences industry, pharma companies are seeking new ways to respond to the high agility required to produce complex products like personalized cancer treatment, cell and gene therapy and Covid-19 vaccines. Central to these efforts is the manufacturing execution system (MES), which allows pharma companies to adopt pharma 4.0 production and manage their data flows to expedite product
NNIT and SCALES enter into a contract with Norlys for the development and implementation of one consolidated Microsoft ERP solution
Under the heading ”OneERP,” NNIT and its subsidiary SCALES will start a project with Norlys to consolidate a number of existing Dynamics and AX solutions into Microsoft Dynamics365 for Finance and Operations.
Interim financial report for Q4 2020/Annual Report just released
NNIT concluded 2020 in line with the financial guidance. Q4 contributed an organic double digit, profitable growth within the Life Sciences International business. The acquisition of Excellis positively added further growth.
NNIT to support COVID-19 vaccine safety data capture
NNIT, a trusted partner of AstraZeneca’s since 2014, will be implementing the critical COVID-19 vaccine post-marketing safety data system.
Acquisition-boosted Orifarm selects NNIT as new strategic IT partner
Orifarm and NNIT have signed a contract for the delivery of end-to-end IT services in connection with Orifarm’s acquisition of a significant portfolio of select over-the-counter (OTC) and prescription pharmaceutical products from Japanese pharmaceutical giant Takeda.
NNIT Group acquires Excellis Health Solutions and continues its Life Sciences growth journey
NNIT acquires US-based Excellis, a leading specialized global provider in end-to-end supply chain consulting services to the life sciences industry.
Interim financial report for Q3 2020 just released
NNIT’s Q3 was driven by double digit profitable growth in the international life sciences segment. The Novo Nordisk Group impacted the growth negatively as expected. In addition, the Private & Public business contracted in Q3.
NNIT signs Solution Provider Program agreement with AWS
Copenhagen, August 27 2020 – NNIT, a leading provider of IT services and consultancy is now deepening the cooperation with Amazon Web Services (AWS) by signing a Solution Provider Program (SPP) agreement. NNIT is now able to manage, service, support and bill customers using AWS, while customers have their own terms with AWS.
The demand for AWS cloud services continues to grow globally. This has